BC Platforms signed an agreement with GeneVault to integrate multimodal genomic, phenomic and clinical datasets from approximately 48 million patients into BC Unify. The datasets cover understudied populations across more than a dozen countries in Asia, the Middle East, Africa and Latin America and will expand BC Platforms’ global data footprint. BC Platforms said the integration will help researchers develop more representative targets and diagnostics by improving access to diverse patient populations. The company positioned the deal as a step to support targeted‑therapy discovery and population‑specific translational research.